Protocol 3: Comprehensive approach (advanced, with medical supervision) Goal: Full-spectrum immune modulation with organ support Phase 1 (Weeks 1-4): Foundation Thymosin alpha-1: 1.6 mg subcutaneously, three times weekly BPC-157: 300 mcg subcutaneously, twice daily Phase 2 (Weeks 5-12): Add modulation Continue Phase 1 peptides Add KPV: 300-500 mcg subcutaneously, once daily Add Selank: 500 mcg intranasally, once daily Phase 3 (Weeks 13-16): Organ support cycle Continue Phase 2 peptides Add Thymalin: 10 mg course over 10 days Add targeted bioregulators based on affected organs (kidney, cardiac, vascular as needed) Phase 4 (Weeks 17-20): Rest and assess Discontinue all peptides Monitor disease activity markers Assess sustained benefits Plan next cycle based on results Monitoring: Full labs every 4 weeks, including CBC, CMP, complement levels, anti-dsDNA, CRP, ESR, urine protein/creatinine ratio

The incidence of severe hyperbilirubinemia (over 340 mmol/L) is approximately 6.8% in Indonesia, with 2% of patients experiencing bilirubin-toxicity consequences (11)
Why is Glutathione Important
Where the peptide enters the body determines where it concentrates, how much reaches systemic circulation, and which tissues it can reach at therapeutic levels
Biology 11(3) Sedaghat R, Taab Y, Kiasalari Z et al (2017) Berberine ameliorates intrahippocampal kainate-induced status epilepticus and consequent epileptogenic process in the rat: underlying mechanisms [J]